Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RUMA clarifies its position on antibiotics
cows
RUMA does not support routine preventative use of antibiotics in the place of better husbandry or farm management.
Position paper addresses "inaccurate assertions"

A "wide-ranging" position paper has been released by the Responsible Use of Medicines in Agriculture Alliance (RUMA), to clarify its position on antibiotic resistance and the use of antibiotics in farming.

The paper also states that it aims to address "inaccurate assertions" made by the Alliance to Save our Antibiotics (ASOA).

Resistance is a hotly debated topic, with the Prime Minister recently commissioning a review to help address the problem.

Last year, the UK's chief medical officer said: "Antibiotic resistance is one of the greatest threats to modern health and we face a future without cures for infection if antibiotics are not used responsibly."

RUMA says it does not support routine preventative use of antibiotics in the place of better husbandry or farm management.

The position paper states that scientific evidence suggests antibiotic resistance in humans is largely down to overuse or misuse in human as opposed to veterinary medicine.

A report by the House of Commons Science and Technology Committee, cited in RUMA's paper,  states that "there is circumstantial evidence that antimicrobial resistance can be transmitted from animal pathogens to human pathogens although the evidence base in incomplete". (Ensuring Access to Working Antimicrobials, paragraph 51).

RUMA says it supports the committee's call for further research in this area and highlights more recent research which found resistant bacteria are genetically different in animals and humans.

RUMA added that there is "no clinical crisis in animal medicine" and antibiotic treatments continue to work.

The alliance called on ASOA and others licensing organic production to allow antibiotics to be used responsibly for the benefit of animal welfare.

Removing certain antibiotics from animal use with put pressure on the remaining classes, thereby increasing, rather than reducing, the risk of resistance developing, RUMA says.

Animal welfare must also be considered. The paper states: "We need to consider very carefully the consequences of of reducing necessary antibiotic use in animals, which can have serious animal welfare/health implications, for possibly no benefit to reducing resistance in humans."

However, RUMA says there must be no complacency about antibiotic use in animals and medicines must be used responsibly in agriculture to prevent problems in animal or human medicine.

Visit RUMA's website for the full paper: http://www.ruma.org.uk/news/20140408.htm

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.